Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
Twenty-two specific-pathogen-free beagles were vaccinated with recombinant OspA (ospA gene derived from Borrelia burgdorferi B31) alone or with adjuvant (QuilA, Montanide ISA25, or aluminum hydroxide) at 6 weeks of age. Thirteen dogs were used as nonvaccinated controls with or without adjuvant. Thre...
保存先:
| 出版年: | Infect Immun |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1995
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC173491/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7642289/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.63.9.3543-3549.1995 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
